Top Markets
#1 MowCat MowCat +776.52%
#2 龙虾 (Lobster) 龙虾 (Lobster) +81.61%
#3 Akedo Akedo +49.11%
#4 Magma Finance Magma Finance +41.92%
#5 DeXe DeXe +31.41%
#6 SIXSEVEN SIXSEVEN +29.75%
#7 Cortex Cortex +26.19%
#8 MarsCoin MarsCoin +25.84%
#9 Zignaly Zignaly +17.71%
#10 Staked ZIG Staked ZIG +17.54%
Coin of the day
MowCat MowCat
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Hisse Senetlerindeki Sıralama #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Hisse Fiyatı
$3.11
Piyasa Değeri
$1.41B
Değişim (1 gün)
-1.97%
Değişim (1 yıl)
-57.22%
Ülke
CN
Ticaret Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Kategori

Healthcare
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204) için gelir
Aug 2026 itibarıyla gelir TTM: 0
Staidson (Beijing) BioPharmaceuticals Co., Ltd. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Staidson (Beijing) BioPharmaceuticals Co., Ltd. için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH